Cardiovascular component of post-COVID-19-syndrome
https://doi.org/10.34215/1609-1175-2022-1-56-64
Abstract
Observation of patients suffering from acute COVID-19 shows that many of them have a long persistence of various symptoms, which often significantly worsen the quality of life and are combined with the concept of "postvoid syndrome". The study of this phenomenon is actively continuing, but its types and manifestations are already known, registers of patients are created, their condition is monitored, and postcovid syndrome is included in the International Classification of Diseases. The review covers predictors, mechanisms of development and main signs of Long-Covid, systemic affection of internal organs, which is explained, among other things, by damaging effect of the virus on different tissues, endothelial dysfunction and micro thrombosis. Particular attention is paid to the causes and types of cardiovascular system disorders. The features of functioning of the world health care system during the pandemic waves which influenced the cardiovascular morbidity and mortality are outlined. It is emphasized that postvascular syndrome is susceptible both to persons who had acute form of COVID and to asymptomatic patients. They equally require medical attention. Electronic means of communication help to provide such care during pandemic period.
About the Authors
Y. V. Vakhnenko
Amur State Medical Academy
Russian Federation
Russian Federation
Yulia V. Vakhnenko - M.D., Assistant, Department of Hospital Therapy with a Course of Pharmacology.
675000, Blagoveshchensk, Amur Region, 97 Gorky St.; тел. +7(924)677-00-08
I. E. Dorovskikh
Amur State Medical Academy
Russian Federation
Russian Federation
Irina E. Dorovskikh - M.D., Head of the Functional Diagnostic Department of the Clinic of Cardiac Surgery.
675000, Blagoveshchensk, Amur region, 97 Gorky str.; тел. +7(924)671-59-58
A. P. Domke
Amur State Medical Academy
Russian Federation
Russian Federation
Alexey P. Domke - M.D., M.D., vascular surgeon at the Cardiosurgery Clinic.
97 Gorky str., Blagoveshchensk, Amur region, 675000; тел. +7(909) 814-20-29
References
1. . Hendren N.S., Drazner M.H., Bozkurt B., Cooper L.T. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome. Circulation. 2020; 141 (23): 1903-1914. doi: 10.1161/CIRCULATIONAHA.120.047349.
2. Khasanova D.R., Zhitkova Y.V., Vaskaeva G.R. Postvoid syndrome: a review of knowledge on pathogenesis, neuropsychiatric manifestations and treatment perspectives. Nevrologiya, nejropsihiatriya, psihosomatika – Neurology, neuropsychiatry, psychosomatics. 2021; 13 (3): 93-98 (in Russ).] DOI: 10.14412/2074-2711- 2021-3-93-98.
3. Dennis A., Wamil M., Kapur S., Alberts J., Badley A.D., Decker G.A., Rizza S.A., Banerjee R., Banerjee A. Multiorgan impairment in low-risk individuals with long COVID. MedRxiv. 2020; DOI: https://doi.org/10.1101/2020.10.14.2 0212555.
4. Greenhalgh T., Knight M., A’Court Ch., Buxton M., Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020; 370: m3026. DOI: 10.1136/bmj.m3026.
5. COVID-19 rapid guideline: managing the long-term effects of COVID-19 // NICE guideline. URL: www.nice.org.uk/guidance/ng188 (Published: 18 December 2020)
6. Tenforde M.W., Kim S.S., Lindsell Ch.J., Rose E.B., Shapiro N.I., Files D.C., Gibbs K.W., Erickson H.L., Steingrub J.S., Smithline H.A., Gong M.N., Aboodi M.S., Exline M.C., Henning D.J., Wilson J.G., Qadir A.K.N., Brown S.M., Peltan I.D., Rice T.W., Hager D.N., Ginde A.A., Stubblefield W.B., Patel M.M., Self W.H., Feldstein L.R. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network – United States, March-June 2020. MMWR Morbidity and Mortality Weekly Report. 2020; 69 (30): 993-998. DOI: 10.15585/mmwr.mm6930e1.
7. Amenta E.M., Spallone A., Rodriguez-Barradas M.C., El Sahly H.M., Atmar R.L., Kulkarni P.A. Postacute COVID-19: An Overview and Approach to Classification. Open Forum Infect Diseases. 2020; 7 (12): DOI: 10.1093/ofid/ofaa509.
8. Belotserkovskaya Y.G., Romanovskikh A.G., Smirnov I.P., Sinopalnikov A.I. Long COVID-19. Consilium Medicum. 2021; 23 (3): 261-268 (in Russ). DOI: 10.26442/20751753.2021.3.200805.
9. Becker R.C. COVID-19 and its sequelae: a platform for optimal patient care, discovery and training. J Thromb Thrombolysis. 2021; (27): 1–8. DOI: 10.1007/s11239-021-02375-w.
10. McKee M. Understanding and managing 'prolonged COVID-19' requires a participatory approach from patients. WHO Regional Office for Europe policy brief "Following the pandemic: preparing for prolonged COVID (2021)". Statement by Professor, European Observatory on Health Systems and Policies. URL: euro.who.int›…media…2021…covid-19…long-covid-post… (25 February 2021).]
11. Sudre C.H., Murray B., Varsavsky Th., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., Molteni E., Modat M., Cardoso M.J., May A., Ganesh S., Davies R., Nguyen L.H., Drew D.A., Astley Ch.M., Joshi A.D., Merino J., Tsereteli N., Fall T., Gomez M.F., Duncan E.L., Menni C., Williams F.M.K., Franks P.W., Chan A.T., Wolf J., Ourselin S., Spector T., Steves C.J. At-tributes and predictors of long COVID. Nat Med. 2021; 27 (4): 626-631. DOI: 10.1038/s41591-021-01292-y.
12. Tay M.Z., Poh Ch.M., Rénia L., MacAry P.A., Ng L.F.P. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020; 20 (6): 363-374. DOI: 10.1038/s41577020-0311-8.
13. Lazgian K.S. Clinical and immunological features of a new coronavirus infection SARS-COV-2 in pregnant women (literature review). Byulleten' fiziologii i patologii dyhaniya – Bulletin of Respiratory Physiology and Pathology. 2021; (80): С.91–99 (in Russ). DOI: 10.36604/1998-5029-2021-80-91-99.
14. Lan L., Xu D., Ye G., Xia Ch., Wang Sh., Li Y., Xu H. Positive RT-PCR Test Results in Patients Recovered From COVID-19. JAMA. 2020; 323 (15): 1502–1503. DOI: 10.1001/jama.2020.278.
15. Aslam S., Mehra M.R. COVID-19: Yet another coronavirus challenge in transplantation. J Heart Lung Transplant. 2020; 39 (5): 408–409. DOI: 10.1016/j.healun.2020.03.007.
16. Monti S., Balduzzi S., Delvino P., Bellis E., Quadrelli V.S., Montecucco C. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis. 2020; 79 (5): 667-668. DOI: 10.1136/annrheumdis-2020-217424.
17. Bunova S.S., Okhotnikova P.I., Skirdenko Y.P., Nikolaev N.A., Osipova O.A., Zhernakova N.I. COVID-19 and cardiovascular comorbidity: search for new approaches to mortality reduction. Kardiovaskulyarnaya terapiya i profilaktika – Cardiovascular Therapy and Prevention. 2021; 20 (4): 122-128 (in Russ). DOI:10.15829/1728-88002021-2953.
18. Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., Mehra M.R., Schuepbach R.A., Ruschitzka F., Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395 (10234): 1417-1418. DOI: 10.1016/S0140-6736(20)30937-5.
19. Yong S.J. Persistent Brainstem Dysfunction in Long-COVID: A Hypothesis. ACS Chem Neurosci. 2021; 12(4): 573–580. Doi: 10.1021/acschemneuro.0c00793.
20. Moreno-Pérez O., Merino E., Leon-Ramirez J-M., Andres M., Ramos J.M., Arenas-Jiménez J., Asensio S., Sanchez R., RuizTorregrosa P., Galan I., Scholz A., Amo A., González-delaAleja P., Boix V., Gil J. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. 2021; 82 (3): 378-383. Doi: 10.1016/j.jinf.2021.01.004.
21. Kukes I.V., Salmasi J.M., Ternovoi K.S., Kazimirsky A.N., Obodzinskaya T.E., Lim V.G., Glagovsky P.B., Mamedov I.S., Poryadin G.V., Savicheva A.S., Kukes E.A., Ptitsyn M.S, Andreev A.D. Prerequisites for creating an atlas of postinflammation as a way to personalized pharmacotherapy as well as prognosis and prevention of organ and systemic dysfunctions. Medical Board. 2021; (12): 72–88 (in Russ). Doi.org/10.21518/2079-701X-2021-12-72-88.
22. Sigfrid L., Drake Th.M., Pauley E., Jesudason E.C., Olliaro P., Lim W. Sh., Gillesen A., Berry C., Lowe D.J., McPeake J., Lone N., Munblit D., Cevik M., Casey A., Bannister P., Russell C.D., Goodwin L., Ho A., Turtle L., O'Hara M.E., Hastie C., Donohue Ch., Spencer R.G., Donegan C., Gummery A., Harrison J., Hardwick H.E., Hastie C.E., Carson G., Merson L., Baillie J.K., Openshaw P., Harrison E.M., Docherty A.B., Semple M.G., Scott J.T. Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. The Lancet. 2021; August 05: DOI:https://doi.org/10.1016/j.lanepe.2021.100186.
23. Estimates of the prevalence of self-reported "long COVID", and the duration of ongoing symptoms following confirmed coronavirus infection, using UK Coronavirus (COVID-19) Infection Survey data to 6 March 2021. Office for National statis-tic. URL: https://www.ons.gov.uk/releases/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk
24. Ayoubkhani D., Khunti K., Nafilyan V., Maddox Th., Humberstone B., Diamond I., Banerjee A. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021; 372:n693. DOI: https://doi.org/10.1136/bmj.n693.
25. Carfì A., Bernabei R., Landi F., Against G. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020; 324 (6): 603605. DOI: 10.1001/jama.2020.12603.
26. Vorobyev A.P., Vorobyev P.A., Mukanin D.A., Krasnova L.S. Effectiveness of the medicase artificial intelligence system in the diagnosis of COVID-19 infection in outpatient settings. Problemy standartizacii v zdravoohranenii – Problems of standardization in public health. 2020; (11-12): 27-36 (in Russ).] DOI: 10.26347/16072502202011-12027-036.
27. Pavli A., Theodoridou M., Maltezou H.C. Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals. Arch Med Res. 2021; 52 (6): 575-581. DOI: 10.1016/j.arcmed.2021.03.010.
28. Gutiérrez-Ortiz C., Méndez-Guerrero A., Rodrigo-Rey S., San Pedro-Murillo E., Bermejo-Guerrero L., Gordo-Mañas R., de Aragón-Gómez F., Benito-León J. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020; 95 (5): e601-e605. DOI: 10.1212/WNL.0000000000009619.
29. Kochi A.N., Tagliari A.P., Forleo G.B., Fassini G.M., Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020; 31 (5): 1003-1008. DOI: 10.1111/jce.14479.
30. Madjid M., Safavi-Naeini P., Solomon S.D., Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiology. 2020; 5 (7): 831-840. DOI: 10.1001/jamacardio.2020.1286.
31. Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt Ch., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., Vehreschild M., Nagel E. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiology. 2020; 5 (11): 1265-1273. DOI: 10.1001/jamacardio.2020.3557.
32. Huang L., Zhao P., Tang D., Zhu T., Han R., Zhan Ch., Liu W., Zeng H., Tao Q., Xia L. Cardiac Involvement in Patients Recovered From COVID-2019 Identified Us-ing Magnetic Resonance Imaging. JACC Cardiovasc Imaging. 2020; 13 (11): 2330-2339. DOI: 10.1016/j.jcmg.2020.05.004.
33. Blagova O.V., Kogan E.A., Lutokhina Yu.A., Kukleva A.D., Ainetdinova D.H., Novosadov V.M., Rud R.S., Zaitsev A.U., Zaydenov V.A., Kupriyanova A.G., Alexandrova S.A., Fomin V.V. Post-acute myoendocarditis of subacute and chronic course: clinical forms, role of coronavirus persistence and autoimmune mechanisms. Cardiology. 2021; 61(6): 11-2 (in Russ). DOI: 10.18087/cardio.2021.6.n1659.
34. Chistyakova MV, Zaitsev DN, Govorin AV, Medvedeva NA, Kurokhtina AA «Postictal» syndrome: morphofunctional changes and heart rhythm disturbances. Rossijskij kardiologicheskij zhurnal – Russian Journal of Cardiology. 2021; 26 (7): 32-39 (in Russ). DOI:10.15829/1560-4071-2021-4485.
35. Rybakova M.K., Mitkov V.V., Khudorozhkova E.D., Baldin D.G., Kotaeva E.A. Echocardiography in the diagnosis of cardiovascular complications in patients undergoing COVID-19 and an algorithm for echocardiographic examination in this patient category. Medicinskij alfavit – Medical alphabet. 2021; (17): 20-31 (in Russ). DOI: 10.33667/2078-5631-2021-17-20-31.
36. Yancy C.W., Fonarow G.C. Coronavirus Disease 2019 (COVID-19) and the Heart-Is Heart Failure the Next Chapter? JAMA Cardiology. 2020; 5 (11): 1216-1217. DOI: 10.1001/jamacardio.2020.3575.
37. Mitrani R.D., Dabas N., Goldberger J.J. COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors. Heart Rhythm. 2020; 17(11): 1984-1990. DOI: 10.1016/j.hrthm.2020.06.026.
38. Sukmarova Z.N., Demyanenko A.V., Gudantov R.B. Relevance of «pulmonary heart syndrome» against the background of pandemic CОVID-19. Voenno-medicinskij zhurnal – Military Medical Journal. 2021; (7): 34-36 (in Russ). DOI: 10.52424/00269050_2021_342_7_34.
39. Podzolkov V.I., Bragina A.E., Tarzimanova A.I., Vasil’eva L.V., Batrakova E.P., Lobova N.V., Bykova E.E., Khachuroeva M.M. I.M. Post-COVID Syndrome and Tachycardia: Theoretical Base and Treatment Experience. Ratsionalnaia Farmakoterapiia v Kardiologii – Rational Pharmacotherapy in Cardiology. 2021; 17(2): 256-262 (in Russ). DOI:10.20996/1819-6446-2021-04-08.
40. Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder Ch., Stevens J.S., Cook J.R., Nordvig A.S., Ausiello J.C., Accili D., Freedberg D.E., Baldwin M., Schwartz A., Brodie D., Garcia C.K., Elkind M.S.V., Connors J.M., Bilezikian J.P., Landry D.W., Wan E.Y. Post-acute COVID-19 syndrome. Nat Med. 2021; (27): 601–615. DOI:10.1038/s41591-021-01283-z.
41. Cheruiyot I., Kipkorir V., Ngure B., Misiani M., Munguti J., Ogeng'o J. Arterial Thrombosis in Coronavirus Disease 2019 Patients: A Rapid Systematic Review. Ann Vasc Surg. . 2021; (70): 273-281. DOI: 10.1016/j.avsg.2020.08.087.
42. Fan B.E., Umapathi T., Chua K., Chia Y.W., Wong Sh.W., Tan G.W.L., Chandrasekar S., Lum Y.H., Vasoo Sh., Dalan R. Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients. J Thromb Thrombolysis. . 2021; 51 (4): 971-977. DOI: 10.1007/s11239-020-02332-z.
43. Dalan R., Boehm B.O. The implications of COVID-19 infection on the endothelium: A metabolic vascular perspective. Diabetes Metab Res Rev. . 2021; 37 (3):e3402. DOI: 10.1002/dmrr.3402.
44. Shakhmatova OO, Panchenko EP, Balakhonova TV, Makeev MI, Mironov VM, Blankova ZN, Butorova EA. Cardiomyopathy and multiple arterial thrombosis in a patient with severe COVID-19 atrial fibrillation tachiform. Aterotromboz – Atherothrombosis. 2021; 11 (1): 6–24 (in Russ). DOI.org/10.21518/2307-1109-2021-11-1-6-24.
45. Bellosta R., Luzzani L., Natalini G., Pegorer M.A., Attisani L., Cossu L.G., Ferrandina C., Fossati A., Conti E., Bush R.L., Piffaretti G. Acute limb ischemia in patients with COVID-19 pneumonia. J Vasc Surg. 2020; 72 (6): 1864-1872. DOI: 10.1016/j.jvs.2020.04.483.
46. Chazova I.E., Mironova O.Yu. COVID-19 and cardiovascular diseases. Terapevticheskij arhiv – Therapeutic archive. 2020; (9): 4-7 (in Russ).] DOI: 10.26442/00403660.2020.09.000742.
47. Butt J.H., Fosbøl E.L., Gerds Th.A., Andersson Ch., Kragholm K., Biering-Sørensen T., Andersen J., Phelps M., Andersen M.P., Gislason G., Torp-Pedersen Ch., Køber L., Schou M. All-cause mortality and location of death in patients with established cardiovascular disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort Study. Eur Heart J. 2021; 42 (15): 1516-1523. DOI: 10.1093/eurheartj/ehab028.
48. Woolley I. Coronavirus disease 2019 (COVID-19): not one epidemic but four. Intern Med J. 2020; 50 (6): 657-658. DOI: 10.1111/imj.14866.
49. Belyakov NA, Trofimova TN, Simakina OE, Rassokhin VV, Serebryakova SL Dynamics of the COVID-19 pandemic and formation of a postcoVID period in Russia. VICH-infekciya i immunosupressii – HIV-infection and immunosuppression. 2021; 13 (2): 7-19 (in Russ). DOI.org/10.22328/2077-9828-2021-13-2-7-19.
50. Long-term effects of coronavirus (long COVID). National Health Service. URL: nhs.uk›…coronavirus-covid-19/longterm-effects-of…(19 August 2021).
51. Zhmerenetsky K.V., Vitko A.V., Petrichko T.A., Vitko L.G., Voronina N.V., Bukhonkina Y.M., Ushakova O.V., Sazonova E.N., Dorofeev A.L., Nevrycheva E.V. Complex issues of managing patients with COVID-19 comorbid in cardiovascular disease and type 2 diabetes 1. Dal'nevostochnyj medicinskij zhurnal – Far Eastern Medical Journal. 2021; (2): 102-114 (in Russ). DOI. org/10.35177/1994-5191-2020-2-101-113.
52. Yeo T.J., Wang Y-T.L., Low T.T. Have a heart during the COVID-19 crisis: Making the case for cardiac rehabilitation in the face of an ongoing pandemic. Eur J Prev Cardiol. 2020; 27 (9): 903-905. DOI: 10.1177/2047487320915665.
Review
For citations:
Vakhnenko Y.V., Dorovskikh I.E., Domke A.P. Cardiovascular component of post-COVID-19-syndrome. Pacific Medical Journal. 2022;(1):56-64. (In Russ.) https://doi.org/10.34215/1609-1175-2022-1-56-64
Views:
564
Email this article 